Q3 2024 OrthoPediatrics Corp Earnings Call

In This Article:

Participants

Trip Taylor

David Bailey; President, Chief Executive Officer; OrthoPediatrics Corp

Fred Hite; Chief Financial Officer, Chief Operating Officer, Director; OrthoPediatrics Corp

Matthew Obrien; Senior Research Analyst; Piper Sandhler

Michael Matson; Senior Analyst; Needham & Company LLC

Presentation

Operator

Good morning and welcome to OrthoPediatrics Corporation's Third Quarter 2024 Earnings Conference Call. At this time, all participants are in listen-only mode. We will be facilitating a question-and-answer session towards the end of today's call.
As a reminder, this call is being recorded for replay purposes. I would now like to turn the call over to Trip Taylor from the Gilmartin Group for a few introductory comments. Please go ahead.

Trip Taylor

Thank you for joining today's call with me from the company are David Bailey, President and Chief Executive Officer and Fred Hite, Chief Operating and Financial Officer. Before we begin today, let me remind you that the company's remarks include forward-looking statements within the meaning of federal securities laws including the safe Harbor provisions of private securities litigation reform Act of 1995. These forward-looking statements are subject to numerous risks and uncertainties and the company's actual results may differ materially for a discussion of risk factors. I encourage you to review the company's most recent annual report on Form 10-K which was filed with the SEC on March 8, 2024. During the call today, management will also discuss certain non-GAAP financial measures which are supplemental measures of performance. The company believes these measures provide useful information for investors in evaluating its operations period over period for each non-GAAP financial measure referenced on this call. The company has included a reconciliation of the non-GAAP financial measures to the most directly comparable GAAP financial measures in its Earnings release. Please note that the non-GAAP financial measures have limitations as analytical tools and should not be considered in isolation or as a substitute for orthopediatric's financial results prepared in accordance with GAAP.
In addition, the content of this conference call contains time sensitive information that is accurate only as of the date of this live broadcast. Today, November 7, 2024. Accepted as required by law, the company undertakes no obligation to revise or update any statements to reflect events or circumstances taking place after the date of this call. With that. I would like to turn the call over to David Bailey, President and Chief Executive Officer.

Waiting for permission
Allow microphone access to enable voice search

Try again.